FDA Gets Senate Funding, House Scolding In Fiscal 2015 Appropriation
This article was originally published in The Tan Sheet
Executive Summary
An omnibus spending agreement gives FDA about a 1.3% increase from its fiscal 2014 appropriation. But the Office of the Commissioner still stands to lose $20 million if FDA does not finalize draft guidance on evaluation and labeling of abuse-deterrent opioids by June 30, 2015.
New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: